<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:News="http://www.bing.com/news/search?q=genetech&amp;FORM=BNFD&amp;format=rss"><channel><title>genetech - BingNews</title><link>http://www.bing.com/news/search?q=genetech&amp;FORM=BNFD&amp;format=rss</link><description>Search results</description><image><url>http://www.bing.com/rsslogo.gif</url><title>genetech</title><link>http://www.bing.com/news/search?q=genetech&amp;FORM=BNFD&amp;format=rss</link></image><copyright>Copyright \xc2\xa9 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><item><title>Genentech highlights new breast cancer and precision oncology data ahead of ASCO 2026 (RHHBY)</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a117f38785b4dcc8ae1c21876dc9182&amp;url=https%3a%2f%2fwww.msn.com%2fen-us%2fmoney%2fgeneral%2fgenentech-highlights-new-breast-cancer-and-precision-oncology-data-ahead-of-asco-2026-rhhby%2far-AA23zHjl&amp;c=3206647880990762573&amp;mkt=en-us</link><description>Roche’s Genentech unit is emphasizing next-generation breast cancer therapies, targeted oncology combinations and brain-penetrating treatments at ASCO 2026. Key Investor Takeaways ・Genentech, part of ...</description><pubDate>Tue, 19 May 2026 07:48:10 GMT</pubDate><News:Source>InvestorsHub on MSN</News:Source><News:Image>http://www.bing.com/th?id=ONUT.l7dGS8aEqTOXObquThjmfA&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>640</News:ImageMaxWidth><News:ImageMaxHeight>351</News:ImageMaxHeight></item><item><title>Genentech is soliciting research that can be used to blunt pharma reforms in Washington</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a117f38785b4dcc8ae1c21876dc9182&amp;url=https%3a%2f%2fwww.statnews.com%2fpharmalot%2f2026%2f05%2f22%2fgenentech-soliciting-academics-write-papers-to-blunt-pharma-reforms-dc%2f&amp;c=11781273135164960939&amp;mkt=en-us</link><description>Earlier this month, Genentech offered countless academics and other researchers up to $125,000 in grants to generate papers about several topics that read like key talking points for a trip to Capitol ...</description><pubDate>Fri, 22 May 2026 06:18:00 GMT</pubDate><News:Source>STAT</News:Source><News:Image>http://www.bing.com/th?id=ONUT.rZSR0aQKdjlpxUtRTPz3-w&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1024</News:ImageMaxWidth><News:ImageMaxHeight>576</News:ImageMaxHeight></item><item><title>Genentech and Sangamo to develop neurodegenerative disease therapies</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a117f38785b4dcc8ae1c21876dc9182&amp;url=https%3a%2f%2ffinance.yahoo.com%2fnews%2fgenentech-sangamo-develop-neurodegenerative-disease-083230099.html&amp;c=14063157139363592607&amp;mkt=en-us</link><description>Sangamo Therapeutics has signed a global licence agreement with Roche Group member Genentech for the development of genomic medicines to treat neurodegenerative diseases. The collaboration focuses on ...</description><pubDate>Tue, 06 Aug 2024 17:00:00 GMT</pubDate><News:Source>Yahoo Finance</News:Source></item><item><title>Genentech timeline</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a117f38785b4dcc8ae1c21876dc9182&amp;url=https%3a%2f%2fwww.sfgate.com%2fnews%2farticle%2fgenentech-timeline-3168365.php&amp;c=7894533458900419796&amp;mkt=en-us</link><description>1976: Genentech founded by venture capitalist Robert Swanson and biochemist Herbert Boyer. 1977-79: Genentech develops genetic engineering techniques to create micro-organisms that can produce insulin ...</description><pubDate>Thu, 12 Mar 2009 17:00:00 GMT</pubDate><News:Source>SFGate</News:Source></item><item><title>Personalization is changing the future of healthcare: What it means</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a117f38785b4dcc8ae1c21876dc9182&amp;url=https%3a%2f%2fwww.msn.com%2fen-us%2fhealth%2fgeneral%2fpersonalization-is-changing-the-future-of-healthcare-what-it-means%2far-AA23Lvjq&amp;c=8842692131347615933&amp;mkt=en-us</link><description>In practice, it could look like more efficiency-and feeling like you're being heard.</description><pubDate>Thu, 21 May 2026 13:50:02 GMT</pubDate><News:Source>Flow Space on MSN</News:Source><News:Image>http://www.bing.com/th?id=ONUT.mK_PXySopxSt1Jp73WHWVg&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>650</News:ImageMaxWidth><News:ImageMaxHeight>433</News:ImageMaxHeight></item><item><title>Ascension bans Genentech sales reps from campus</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a117f38785b4dcc8ae1c21876dc9182&amp;url=https%3a%2f%2fwww.healthcaredive.com%2fnews%2fascension-bans-genentech-sales-reps-from-campus%2f317098%2f&amp;c=15332348284672111618&amp;mkt=en-us</link><description>In response to Genetech's change in how it ships three high profile cancer drugs to hospitals, at least one health system has responded by kicking Genentech reps off the premises. Many hospitals worry ...</description><pubDate>Sun, 05 Oct 2014 17:00:00 GMT</pubDate><News:Source>Healthcare Dive</News:Source></item><item><title>Genentech weighs slow-walking ovarian cancer therapy to make more money under drug pricing reform</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a117f38785b4dcc8ae1c21876dc9182&amp;url=https%3a%2f%2fwww.statnews.com%2f2023%2f08%2f10%2fgenentech-drug-price-cancer%2f&amp;c=5666264632284536112&amp;mkt=en-us</link><description>WASHINGTON — Plenty of pharmaceutical executives have decried Democrats’ new drug pricing law as detrimental to the industry. But few are willing to say they may be willing to delay treatments for ...</description><pubDate>Wed, 09 Aug 2023 17:00:00 GMT</pubDate><News:Source>STAT</News:Source></item><item><title>Genentech makes a flurry of marketing leadership hires</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a117f38785b4dcc8ae1c21876dc9182&amp;url=https%3a%2f%2fwww.mmm-online.com%2fhome%2fchannel%2fgenentech-makes-a-flurry-of-marketing-leadership-hires%2f&amp;c=13516393796643802167&amp;mkt=en-us</link><description>Genentech recently announced a series of marketing leadership hires to start off the new year. The biotech company hired Erica Taylor, PhD, as the company’s first chief marketing officer and tabbed ...</description><pubDate>Tue, 03 Jan 2023 16:00:00 GMT</pubDate><News:Source>MM&amp;M</News:Source></item><item><title>Roche completes purchase of Genentech</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a117f38785b4dcc8ae1c21876dc9182&amp;url=https%3a%2f%2fwww.sfgate.com%2ftech%2farticle%2froche-completes-purchase-of-genentech-3167420.php&amp;c=4377774985010178052&amp;mkt=en-us</link><description>Swiss drugmaker Roche said Thursday it completed its acquisition of biotechnology pioneer Genentech Inc. after sweeping up enough shares through a tender offer to gain ownership of more than 93 ...</description><pubDate>Thu, 26 Mar 2009 17:00:00 GMT</pubDate><News:Source>SFGate</News:Source></item><item><title>Roche to take over Genentech for $47 billion</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a117f38785b4dcc8ae1c21876dc9182&amp;url=https%3a%2f%2fwww.latimes.com%2farchives%2fla-xpm-2009-mar-13-fi-genentech13-story.html&amp;c=14265609467479686913&amp;mkt=en-us</link><description>The pharmaceutical industry’s wave of consolidation hit California on Thursday with the announcement of two major deals, including Swiss drug giant Roche’s agreement to pay $47 billion to gain full ...</description><pubDate>Thu, 12 Mar 2009 17:00:00 GMT</pubDate><News:Source>Los Angeles Times</News:Source></item><item><title>The Fight To Keep Genentech's Genius</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a117f38785b4dcc8ae1c21876dc9182&amp;url=https%3a%2f%2fwww.forbes.com%2f2009%2f03%2f12%2fgenentech-roche-merger-business-health-care-genetech.html&amp;c=1763021114181324755&amp;mkt=en-us</link><description>Will Roche 's $47 billion purchase of Genentech unleash an exodus of the very scientists that made the biotech so valuable? Not if Roche Chairman Franz Humer can help it. He says he'll do whatever it ...</description><pubDate>Thu, 12 Mar 2009 16:24:00 GMT</pubDate><News:Source>Forbes</News:Source></item></channel></rss>